Skip to content

Childhood study on respiratory pathogens from induced sputum

Childhood study on respiratory pathogens from induced sputum - Induced sputum

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON35654
Enrollment
100
Registered
2009-09-25
Start date
2009-10-12
Completion date
Unknown
Last updated
2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

'lower respiratory tract infections' 'lung infection'

Interventions

None listed

Sponsors

Jeroen Bosch Ziekenhuis
Lead Sponsor

Eligibility

Age
2 Years to 17 Years

Inclusion criteria

Inclusion criteria: Tachypnea combined with at least one of: elevated body temperature, cough, dyspnea or abdominal pain

Exclusion criteria

Exclusion criteria: - Acute exacerbation of asthma in the last 4 weeks. This is defined as requiring systemic coricosteroids, hospital admission and/or use of ß-sympaticomimetics >400 µg per day - Oxygen saturation

Design outcomes

Primary

MeasureTime frame
The quality of induced sputum, defined as 25 leukocytes per visual field under light microscopy.

Secondary

MeasureTime frame
To identify bacterial and viral pathogens of lower respiratory tract infections. To determine the practical applicability of sputum induction in general pediatric practice. To determine the prevalence of Coxiella burnetii infections (Q fever) in children with lower respiratory tract infections. To determine the prevalence of Influenza A type H1N1-infections in children with lower respiratory tract infections.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)